DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Bortezomib
Bortezomib
Bortezomib (INN, originally codenamed PS-341; marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
Bortezomib - List of case studies
- IgG Multiple Myeloma
-
failure. Unfortunately, he relapsed and was treated with bortezomib and steroids for 6 cycles followed by thalidomide. The disease has ... in your opinion on his current treatment? Bortezomib is the most active agent currently available for the treatment of ...
- Multiple Myeloma (MM) and Cardiomyopathy
-
received anti-MM induction type of treatment, including bortezomib (velcade), thalidomide and dexamethasone (the VTD combination x3), ... thalidomide and dexamthasone ( ThalDex ) and leaving the bortezomib for later disease stages, or using revlimid (lenalidomide) with ...
- Drugs
-
drugs Blopresid Borage oil Boric water Bortezomib Boswellia Botulinium toxin Botulinum toxin ...